Form 10-Q QUEST DIAGNOSTICS INC For: Sep 30

Go back to Form 10-Q QUEST DIAGNOSTICS INC For: Sep 30

Quest Diagnostics (DGX) PT Raised to $210 at Leerink Partners

October 21, 2025 1:09 PM EDT

Leerink Partners analyst Michael Cherny raised the price target on Quest Diagnostics (NYSE: DGX) to $210.00 (from $203.00) while maintaining a Outperform rating.

The analyst comments "DGX's 3Q results were another proof point of the near-Goldilocks environment in the lab space, with the... More